Alfuzosin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In medicine, '''alfuzosin''' is a selective antagonist of alpha1-adrenergic receptors. ==External links== {{CZMed}}) |
Pat Palmer (talk | contribs) m (Text replacement - "United States" to "United States of America") |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. | In [[medicine]], '''alfuzosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. | ||
==History== | |||
Uroxatral brand of alfuzosin was approved by the [[Food and Drug Administration]] in the [[United States of America]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=021287 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=079013 Drugs@FDA]. U S Food and Drug Administration</ref> | |||
<!-- | |||
==Pharmacology== | |||
===Administration=== | |||
===Distribution=== | |||
===Metabolism=== | |||
===Excretion=== | |||
===Toxicity=== | |||
--> | |||
==External links== | ==External links== | ||
{{CZMed}} | {{CZMed}} | ||
==References== | |||
<references/> | |||
Latest revision as of 11:47, 2 February 2023
In medicine, alfuzosin is a selective antagonist of alpha1-adrenergic receptors.
History
Uroxatral brand of alfuzosin was approved by the Food and Drug Administration in the United States of America with a New Drug Application (NDA) in 2003.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2009.[2]
External links
The most up-to-date information about Alfuzosin and other drugs can be found at the following sites.
- Alfuzosin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Alfuzosin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Alfuzosin - Detailed information from DrugBank.